5 Warren Buffett Stocks To Buy For Under $25
Berkshire (BRK/A) Takes Activision Blizzard (ATVI) Stake, Exits Teva (TEVA) - Bloomberg
Warren Buffett reduces stake in Teva - Globes
Warren Buffett seals investment on Teva Pharmaceutical
Berkshire buys Teva, bites more Apple, feels IBM blues | Fox Business
Teva gets a boost as billionaire Buffett reports $358M stake | Fierce Pharma
Warren Buffett's Berkshire Hathaway increases stake in Apple
Warren Buffett loses nearly $300m on Teva - Globes
Warren Buffett wagers big on Teva, and on Israel - Israel News - The Jerusalem Post
5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter | The Motley Fool
Berkshire Hathaway Takes Position in Generic Drugmaker Teva | Ctech
Warren Buffett's Berkshire Hathaway Inc loads up on Apple Inc, Teva Pharmaceuticals Ltd, Goldman Sachs Group Inc
Warren Buffett Q1 2018 stock buys and sells
Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel
TEVA: 1 Stock Warren Buffett Might Have Sold Too Soon
Warren Buffett's firm adds to Apple, Teva investments
Warren Buffett's Berkshire dumps IBM, buys Teva as Apple becomes top investment - BNN Bloomberg
Buffett's Berkshire Hathaway doubles shares of Teva
Warren Buffett and Berkshire Hathaway are beating the market this year | CNN Business
Why Warren Buffett's Berkshire loves loathed Israeli drug stock Teva
Why Warren Buffett's Berkshire loves loathed Israeli drug stock Teva
Why in the World Does Warren Buffett Like Teva Pharmaceutical? | The Motley Fool
Huge losses: Warren Buffett sold his holdings in Teva - time.news - Time News
Warren Buffett Berkshire Hathaway Losing Millions on Teva Pharma - Jewish Business News
:max_bytes(150000):strip_icc()/warren_buffett-5bfc322f46e0fb0051bf123c.jpg "Buffett's Berkshire Hathaway Adds Apple and Teva Shares, Dumps IBM")
Buffett's Berkshire Hathaway Adds Apple and Teva Shares, Dumps IBM
Warren Buffett Offered Uber a $3 Billion Investment, but Talks Fell Apart - WSJ
Why Warren Buffett's Still Gobbling Up Shares in This Generic Drugmaker | The Motley Fool
